{"qas": [{"question": "Who were some of the companies that encouraged the interactions between doctors and the pharmaceutical industry?", "id": "571af11632177014007e9ff8", "answers": [{"text": "World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration", "answer_start": 612}], "is_impossible": false}, {"question": "When did the article come out about the importance of interactions?", "id": "571af11632177014007e9ff9", "answers": [{"text": "May 2015", "answer_start": 109}], "is_impossible": false}, {"question": "What was the reason behind these interactions?", "id": "571af11632177014007e9ffa", "answers": [{"text": "bring greater benefits to patients", "answer_start": 793}], "is_impossible": false}, {"question": "What was believed to have created a financial conflict of interest?", "id": "571af11632177014007e9ffb", "answers": [{"text": "moral outrage over industry malfeasance", "answer_start": 251}], "is_impossible": false}, {"question": "Who printed the article about the importance of interactions?", "id": "571af11632177014007e9ffc", "answers": [{"text": "New England Journal of Medicine", "answer_start": 74}], "is_impossible": false}, {"question": "What publication had an article about the importance of pharmaceutical industry-physician interactions in 2015?", "id": "571d26ce5efbb31900334eae", "answers": [{"text": "New England Journal of Medicine", "answer_start": 74}], "is_impossible": false}, {"question": "When was the editorial published?", "id": "571d26ce5efbb31900334eaf", "answers": [{"text": "May 2015", "answer_start": 109}], "is_impossible": false}, {"question": "Did major healthcare organizations support or discourage interactions between doctors and industries?", "id": "571d26ce5efbb31900334eb0", "answers": [{"text": "encouraged greater interactions", "answer_start": 717}], "is_impossible": false}, {"plausible_answers": [{"text": "World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration", "answer_start": 612}], "question": "Who were some of the companies that encouraged the interactions between doctors and the National Center for Advancing Translational Sciences of the National Institutes of Health?", "id": "5ad39d84604f3c001a3fe8e1", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "May 2015", "answer_start": 109}], "question": "When did the article come out about the importance of doctors?", "id": "5ad39d84604f3c001a3fe8e2", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "bring greater benefits to patients", "answer_start": 793}], "question": "What was the reason behind these conflicts?", "id": "5ad39d84604f3c001a3fe8e3", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "moral outrage over industry malfeasance", "answer_start": 251}], "question": "What was believed to have created physician interactions?", "id": "5ad39d84604f3c001a3fe8e4", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "New England Journal of Medicine", "answer_start": 74}], "question": "Who printed the article about the importance of malfeasance?", "id": "5ad39d84604f3c001a3fe8e5", "answers": [], "is_impossible": true}], "context": "In contrast to this viewpoint, an article and associated editorial in the <a4_0><a5_0><b12_0>New England Journal of Medicine<b12_0/><a5_0/><a4_0/> in <a1_0><a6_0><b9_0>May 2015<b9_0/><a6_0/><a1_0/> emphasized the importance of pharmaceutical industry-physician interactions for the development of novel treatments, and argued that <a3_0><b11_0>moral outrage over industry malfeasance<b11_0/><a3_0/> had unjustifiably led many to overemphasize the problems created by financial conflicts of interest. The article noted that major healthcare organizations such as National Center for Advancing Translational Sciences of the National Institutes of Health, the President\u2019s Council of Advisors on Science and Technology, the <a0_0><b8_0>World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration<b8_0/><a0_0/> had <a7_0>encouraged greater interactions<a7_0/> between physicians and industry in order to <a2_0><b10_0>bring greater benefits to patients<b10_0/><a2_0/>."}